DJO today said it acquired LiteCure and its therapeutic laser technology for an undisclosed amount.
New Castle, Del.-based LiteCure’s portfolio includes products marketed under the brand names of LightForce Therapy Lasers for humans and Companion for animals.
“The LiteCure portfolio was a natural fit for the DJO Recovery Sciences business, bringing together a joint passion for innovation and clinically proven technology,” DJO CEO Brady Shirley said in a news release. “The acquisition will strengthen our leadership position in physical therapy and rehabilitation — and reinforces our commitment to keeping people active, enabling our customers to better serve their patients.”
LightForce Therapy Lasers are used to treat chronic and acute musculoskeletal conditions as well as post-activity recovery, according to the company. It is a non-drug, non-surgical solution designed to reduce inflammation and pain without the side effects of medication. The lasers have been used in physical therapy, chiropractic, podiatry and dentistry applications.
DJO officials identified immediate synergies with the company’s Chattanooga rehabilitation business.
“The LiteCure portfolio complements and expands Chattanooga’s innovative rehabilitation therapies,” DJO president Terry Ross said. “Together, we will bring leading technologies and treatment modalities designed to enhance patient outcomes and practice efficiency to our customers around the world.”
“With DJO’s expanded reach and resources, we are excited to increase awareness and adoption of deep tissue laser therapy,” LiteCure founder and CEO Brian Pryor said. “We are passionate about the clinical benefits of photobiomodulation as well as the benefits it brings to a practice when adding this modality.”
